iCliniq Logo
Dr. Daniel Howell
Dr. Daniel Howell

Dr. Daniel Howell

MBBS, MSc
New York, United States
Joined iCliniq in2020
Star 2

11+

Years of
experience

Star 3

50

Patients
treated

Starting from $49

Feed

About

Reviews

Professional Bio

Dr. Daniel Howell specializes in Internal Medicine with a special interest in lung conditions such as asthma, COPD, interstitial lung disease, and pulmonary embolism. He is skilled in respiratory diagnostics, chronic disease management, and evidence-based treatment planning. With a patient-centered approach, Dr. Howell focuses on improving lung function, preventing complications, and enhancing quality of life. His clinical expertise ensures comprehensive care for a wide range of pulmonary and internal health issues.

Education

MBBS

Newcastle University

2012

MSc

University College London

2017

Awards and Publications

Dr. Daniel Howell has written the following: Manuscripts - 1. Mathews KS, Howell D. Risks of removing the default: Lung protective ventilation is for everyone. CHEST Physician. 2019 14(4): 42-43; 2. Howell D, Zaremski L, Fisher J, Ferrick K, DiBiase L, et al. Bleeding Risk with Apixaban when Using Cardiac P-Glycoprotein Inhibitors. Int J Clin Cardiol Res. 2018;2(3): 061-065; 3. Howell D, Galen BT Recurrent rheumatoid pleural effusions complicated by Mycobacterium heckeshornense infection. Respiratory medicine case reports 2018 25 333-335. Abstracts - 1. Andrae M, Mathews KS, Howell D, Zhang Q, Richardson L Patient Preferences for Proactive Consent for Multiple Clinical Trials Society of Critical Care Medicine February 2020; 2. Howell D, Zaremski L, Gross JN, Romero J, Kim S, Di Biase L, Fisher JD, Ferrick K, Krumerman A. Risk With Co-administration Of Commonly Used Cardiac P-glycoprotein Inhibitors And Apixaban. American Heart Association, Toronto November 2017; 3. Colvin MO, Gibson CD, Howell D, Kalininsky A, Lorenzen SJ, Hsieh SJ, Gershengorn H. Effectiveness of early mobilization in reducing the rate of thromboembolic disease among adult medical ICU patient. CHEST, Toronto, October 2017; 4. Amell F, Shetha P, Howell D, Merkin R, LeFrancois D, Elwyn G. Preference Agnosia in Practice Questions for Medical Licensing and Board Examinations. 5th Annual Lown Conference in Boston. (2017) Presentation of abstract won 2nd place; 5. Howell D, Warhit M, Bhargava A and Galen BT. Recurrent Rheumatoid Pleural Effusions Complicated by Mycobacterium heckeshornense Infection. Society of General Internal Medicine annual meeting. Washington DC May 2017. Posters - 1. Howell D., Hoch E., Shulman E., Gross JN, Romero J, Kim S, Di Biase L, Fisher JD, Ferrick K, Krumerman A. Ethan Hoch, Eric Shulman, Luigi Di Biase, Kevin J Ferrick, John Fisher, Andrew Krumerman. Interaction between amiodarone and rivaroxaban and the risk of major bleeding. Heart Rhythm, Vol. 13 No. 5 May Supplement 2016 and published abstract. 2. Christofi G, Chandratheva A, Walters C, Howell D, Simister R The value of medical intervention within an early supported discharge team: a prospective cohort study. European Stroke Journal May 2016, vol 1, issue 1 suppl pg 5281. Poster and published abstract. 3. Howell D, Shaines M Musculoskeletal chest pain: Not just a diagnosis of exclusion. Society of General Internal Medicine May 2016 Howell D, Nelligan L Shortening wait times for transfer to a PCI center for patients with NSTE-ACS. Oxford Foundation Symposium October 2013.

Languages

English, French

Clinic

Dr Daniel Howell
111 E 210th St, Bronx,New York,10467, United States.